315 related articles for article (PubMed ID: 36826126)
1. The Landscape of Immunotherapy for Retroperitoneal Sarcoma.
Gingrich AA; Nassif EF; Roland CL; Keung EZ
Curr Oncol; 2023 Feb; 30(2):2144-2158. PubMed ID: 36826126
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy in Sarcoma: Where Do Things Stand?
Moreno Tellez C; Leyfman Y; D'Angelo SP; Wilky BA; Dufresne A
Surg Oncol Clin N Am; 2022 Jul; 31(3):381-397. PubMed ID: 35715140
[TBL] [Abstract][Full Text] [Related]
3. Practical Management of Adult Ultra-Rare Primary Retroperitoneal Soft Tissue Sarcoma: A Focus on Perivascular Epithelioid Tumours and Extraosseous Ewing Sarcoma.
Apte SS; Mor E; Mitchell C; Gyorki DE
Curr Oncol; 2023 Jun; 30(7):5953-5972. PubMed ID: 37504306
[TBL] [Abstract][Full Text] [Related]
4. Molecular Determinants of Soft Tissue Sarcoma Immunity: Targets for Immune Intervention.
Tazzari M; Bergamaschi L; De Vita A; Collini P; Barisella M; Bertolotti A; Ibrahim T; Pasquali S; Castelli C; Vallacchi V
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299136
[TBL] [Abstract][Full Text] [Related]
5. Breaking down the tumor immune infiltration within pediatric sarcomas.
Weil R; Loeb D
Front Endocrinol (Lausanne); 2023; 14():1187289. PubMed ID: 37424864
[TBL] [Abstract][Full Text] [Related]
6. Sarcomas: Immune biomarker expression and checkpoint inhibitor trials.
Zhu MMT; Shenasa E; Nielsen TO
Cancer Treat Rev; 2020 Dec; 91():102115. PubMed ID: 33130422
[TBL] [Abstract][Full Text] [Related]
7. New developments in the pathology and molecular biology of retroperitoneal sarcomas.
Watson S; Gruel N; Le Loarer F
Eur J Surg Oncol; 2023 Jun; 49(6):1053-1060. PubMed ID: 35151525
[TBL] [Abstract][Full Text] [Related]
8. Immunotherapy and Biomarkers in Sarcoma.
Dajsakdipon T; Siripoon T; Ngamphaiboon N; Ativitavas T; Dejthevaporn T
Curr Treat Options Oncol; 2022 Mar; 23(3):415-438. PubMed ID: 35262852
[TBL] [Abstract][Full Text] [Related]
9. The Role of Immunotherapy in the Management of Soft Tissue Sarcomas: Current Landscape and Future Outlook.
Banks LB; D'Angelo SP
J Natl Compr Canc Netw; 2022 Jul; 20(7):834-844. PubMed ID: 35830892
[TBL] [Abstract][Full Text] [Related]
10. Role of Immunotherapy in Sarcomas.
Dalal S; Shan KS; Thaw Dar NN; Hussein A; Ergle A
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38279265
[TBL] [Abstract][Full Text] [Related]
11. Immunotherapy for sarcomas.
Nakata E; Fujiwara T; Kunisada T; Ito T; Takihira S; Ozaki T
Jpn J Clin Oncol; 2021 Apr; 51(4):523-537. PubMed ID: 33611603
[TBL] [Abstract][Full Text] [Related]
12. Sarcoma Immunotherapy: Confronting Present Hurdles and Unveiling Upcoming Opportunities.
Jeong S; Afroz S; Kang D; Noh J; Suh J; Kim JH; You HJ; Kang HG; Kim YJ; Kim JH
Mol Cells; 2023 Oct; 46(10):579-588. PubMed ID: 37853684
[TBL] [Abstract][Full Text] [Related]
13. Retroperitoneal Sarcomas: Histology Is Everything.
Turgeon MK; Cardona K
Surg Clin North Am; 2022 Aug; 102(4):601-614. PubMed ID: 35952690
[TBL] [Abstract][Full Text] [Related]
14. Management of Locally Recurrent Retroperitoneal Sarcoma in the Adult: An Updated Consensus Approach from the Transatlantic Australasian Retroperitoneal Sarcoma Working Group.
Tseng WW; Swallow CJ; Strauss DC; Bonvalot S; Rutkowski P; Ford SJ; Gonzalez RJ; Gladdy RA; Gyorki DE; Fairweather M; Lee KW; Albertsmeier M; van Houdt WJ; Fau M; Nessim C; Grignani G; Cardona K; Quagliuolo V; Grignol V; Farma JM; Pennacchioli E; Fiore M; Hayes A; Tzanis D; Skoczylas J; Almond ML; Mullinax JE; Johnston W; Snow H; Haas RL; Callegaro D; Smith MJ; Bouhadiba T; Desai A; Voss R; Sanfilippo R; Jones RL; Baldini EH; Wagner AJ; Catton CN; Stacchiotti S; Thway K; Roland CL; Raut CP; Gronchi A;
Ann Surg Oncol; 2022 Nov; 29(12):7335-7348. PubMed ID: 35767103
[TBL] [Abstract][Full Text] [Related]
15. Updates in Pathology for Retroperitoneal Soft Tissue Sarcoma.
Mack T; Purgina B
Curr Oncol; 2022 Sep; 29(9):6400-6418. PubMed ID: 36135073
[TBL] [Abstract][Full Text] [Related]
16. Tumor DNA methylation profiles correlate with response to anti-PD-1 immune checkpoint inhibitor monotherapy in sarcoma patients.
Starzer AM; Berghoff AS; Hamacher R; Tomasich E; Feldmann K; Hatziioannou T; Traint S; Lamm W; Noebauer-Huhmann IM; Furtner J; Müllauer L; Amann G; Bauer S; Schildhaus HU; Preusser M; Heller G; Brodowicz T
J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33762319
[TBL] [Abstract][Full Text] [Related]
17. Emerging predictive biomarkers in the management of bone and soft tissue sarcomas.
Haddox CL; Riedel RF
Expert Rev Anticancer Ther; 2023 May; 23(5):495-502. PubMed ID: 37017995
[TBL] [Abstract][Full Text] [Related]
18. Management of primary retroperitoneal sarcoma (RPS) in the adult: a consensus approach from the Trans-Atlantic RPS Working Group.
Trans-Atlantic RPS Working Group
Ann Surg Oncol; 2015 Jan; 22(1):256-63. PubMed ID: 25316486
[TBL] [Abstract][Full Text] [Related]
19. Management of Primary Retroperitoneal Sarcoma (RPS) in the Adult: An Updated Consensus Approach from the Transatlantic Australasian RPS Working Group.
Swallow CJ; Strauss DC; Bonvalot S; Rutkowski P; Desai A; Gladdy RA; Gonzalez R; Gyorki DE; Fairweather M; van Houdt WJ; Stoeckle E; Park JB; Albertsmeier M; Nessim C; Cardona K; Fiore M; Hayes A; Tzanis D; Skoczylas J; Ford SJ; Ng D; Mullinax JE; Snow H; Haas RL; Callegaro D; Smith MJ; Bouhadiba T; Stacchiotti S; Jones RL; DeLaney T; Roland CL; Raut CP; Gronchi A;
Ann Surg Oncol; 2021 Nov; 28(12):7873-7888. PubMed ID: 33852100
[TBL] [Abstract][Full Text] [Related]
20. Emerging Trends in Immunotherapy for Adult Sarcomas.
Husain M; Chen L; Liebner D; Beane J; Rubinstein M; Pollock R; Verschraegen C; Tinoco G
Oncologist; 2023 May; 28(5):e233-e241. PubMed ID: 36905579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
